Bleomycins: New methods will allow reinvestigation of old issues

Current Opinion in Chemical Biology

Volumn 8, Issue 2, 2004, Pages 175-181

  Chen, Jingyang ^a   Stubbe, JoAnne ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

3 PG 5 P; 3 phosphoglycolate, 5 phosphate lesion; Bleomycin; BLM; Double stranded; ds; Electron nuclear double resonance; ENDOR; Phleomycin; PLM; Single stranded; ss

Indexed keywords

BLEOMYCIN;

CELL NUCLEUS; DNA DAMAGE; DNA DEGRADATION; DNA REPAIR; DRUG CYTOTOXICITY; DRUG STRUCTURE; HUMAN; NONHUMAN; OXIDATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; REVIEW;

ANTIMETABOLITES, ANTINEOPLASTIC; BLEOMYCIN; DNA DAMAGE; METALS, HEAVY; MOLECULAR STRUCTURE;

EID: 1842426944     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2004.02.008     Document Type: Review

References (39)

1. Sleijfer S. Bleomycin-induced pneumonitis. Chest. 120:2001;617-624.
2. Burger R.M. Cleavage of nucleic acids by bleomycin. Chem Rev. 98:1998;1153-1169.
3. Boger D.L., Cai H. Bleomycin: synthetic and mechanistic studies. Angew Chem Int Ed Engl. 38:1999;449-476.
4. Claussen C.A., Long E.C. Nucleic acid recognition by metal complexes of bleomycin. Chem Rev. 99:1999;2797-2816.
5. Povirk L.F. DNA damage and mutagenesis by radiomimetic DNA-cleaving agents: bleomycin, neocarzinostatin and other enediynes. Mutat Res. 355:1996;71-89.
6. Abraham A.T., Lin J.J., Newton D.L., Rybak S., Hecht S.M. RNA cleavage and inhibition of protein synthesis by bleomycin. Chem Biol. 10:2003;45-52 BLM can cleave selected members of rRNA, mRNA and tRNA. This paper demonstrates the correlation of protein synthesis inhibition with RNA cleavage, suggesting a new mode of cytotoxicity.
7. Smith K.L., Tao Z.F., Hashimoto S., Leitheiser C.J., Wu X., Hecht S.M. Deglycobleomycin: solid-phase synthesis and DNA cleavage by the resin-bound ligand. Org Lett. 4:2002;1079-1082.
8. Hecht S.M. Bleomycin: new perspectives on the mechanism of action. J Nat Prod. 63:2000;158-168.
9. Thomas C.J., Chizhov A.O., Leitheiser C.J., Rishel M.J., Konishi K., Tao Z.F., Hecht S.M. Solid-phase synthesis of bleomycin A(5) and three monosaccharide analogues: exploring the role of the carbohydrate moiety in RNA cleavage. J Am Chem Soc. 124:2002;12926-12927.
10. Stubbe J., Kozarich J.W., Wu W., Vanderwall D.E. Bleomycins: A structural model for specificity, binding, and double strand cleavage. Acc Chem Res. 29:1996;322-330.
11. Boger D.L., Ramsey T.M., Cai H., Hoehn S.T., Stubbe J.A. A systematic evaluation of the bleomycin A(2) L-threonine side chain: Its role in preorganization of a compact conformation implicated in sequence-selective DNA cleavage. J Am Chem Soc. 120:1998;9139-9148.
12. Boger D.L., Ramsey T.M., Cai H., Hoehn S.T., Stubbe J. Definition of the effect and role of the bleomycin A(2) valerate substituents: preorganization of a rigid, compact conformation implicated in sequence-selective DNA cleavage. J Am Chem Soc. 120:1998;9149-9158.
13. Du L., Sanchez C., Chen M., Edwards D.J., Shen B. The biosynthetic gene cluster for the antitumor drug bleomycin from Streptomyces verticillus ATCC15003 supporting functional interactions between nonribosomal peptide synthetases and a polyketide synthase. Chem Biol. 7:2000;623-642 The discovery of the long-sought genes for the biosynthesis of BLM offers new opportunities for investigation of the role of the carbohydrate moiety of BLMs.
14. Wittmann V., Wong C.H. 1H-tetrazole as catalyst in phosphomorpholidate coupling reactions: efficient synthesis of GDP-fucose, GDP-mannose, and UDP-galactose. J Org Chem. 62:1997;2144-2147.
15. Barton W.A., Biggins J.B., Jiang J., Thorson J.S., Nikolov D.B. Expanding pyrimidine diphosphosugar libraries via structure-based nucleotidylyltransferase engineering. Proc Natl Acad Sci USA. 99:2002;13397-13402.
16. Barton W.A., Lesniak J., Biggins J.B., Jeffrey P.D., Jiang J., Rajashankar K.R., Thorson J.S., Nikolov D.B. Structure, mechanism and engineering of a nucleotidylyltransferase as a first step toward glycorandomization. Nat Struct Biol. 8:2001;545-551.
17. Petering D.H., Byrnes R.W., Antholine W.E. The role of redox-active metals in the mechanism of action of bleomycin. Chem Biol Interact. 73:1990;133-182.
18. 3+-OOH, negating interpretation of earlier studies on Co(III)-pepleomycin [39].
19. 3+-OOH.
20. Kemsley J.N., Zaleski K.L., Chow M.S., Decker A., Shishova E.Y., Wasinger E.C., Hedman B., Hodgson K.O., Solomon E.I. Spectroscopic studies of the interaction of ferrous bleomycin with DNA. J Am Chem Soc. 125:2003;10810-10821.
21. Lehmann T.E. Molecular modeling of the three-dimensional structure of Fe(II)-bleomycin: are the Co(II) and Fe(II) adducts isostructural? J Biol Inorg Chem. 7:2002;305-312.
22. 19F of 2′-fluorocytidine in a DNA target sequence J Am Chem Soc. 123:2001;12742-12743.
23. Fulmer P., Zhao C., Li W., DeRose E., Antholine W.E., Petering D.H. Fe- and Co-bleomycins bound to site specific and nonspecific DNA decamers: comparative binding and reactivity of their metal centers. Biochemistry. 36:1997;4367-4374.
24. Loeb K.E., Zaleski J.M., Hess C.D., Hecht S.M., Solomon E.I. Spectroscopic investigation of the metal ligation and reactivity of the ferrous active sites of bleomycin and bleomycin derivatives. J Am Chem Soc. 120:1998;1249-1259.
25. Ehrenfeld G.M., Shipley J.B., Heimbrook D.C., Sugiyama H., Long E.C., van Boom J.H., van der Marel G.A., Oppenheimer N.J., Hecht S.M. Copper- dependent cleavage of DNA by bleomycin. Biochemistry. 26:1987;931-942.
26. Neese F., Zaleski J.M., Zaleski K.L., Solomon E.I. Electronic structure of activated bleomycin: oxygen intermediates in heme versus non-heme iron. J Am Chem Soc. 122:2000;11703-11724.
27. Lehnert N., Neese F., Ho R.Y., Que L. Jr., Solomon E.I. Electronic structure and reactivity of low-spin Fe(III)-hydroperoxo complexes: comparison to activated bleomycin. J Am Chem Soc. 124:2002;10810-10822 Calculations in an effort to guide thinking about the reactivity of low spin non-heme iron peroxides.
28. Worth L. Jr., Frank B.L., Christner D.F., Absalon M.J., Stubbe J., Kozarich J.W. Isotope effects on the cleavage of DNA by bleomycin: mechanism and modulation. Biochemistry. 32:1993;2601-2609.
29. Price J.C., Barr E.W., Tirupati B., Bollinger J.M. Jr., Krebs C. The first direct characterization of a high-valent iron intermediate in the reaction of an alpha-ketoglutarate-dependent dioxygenase: a high-spin FeIV complex in taurine/alpha-ketoglutarate dioxygenase (TauD) from Escherichia coli. Biochemistry. 42:2003;7497-7508.
30. 2. Efficient, double-strand DNA cleavage accessible without structural reorganization. J Am Chem Soc. 123:2001;8690-8700.
31. Hoehn S.T., Junker H.D., Bunt R.C., Turner C.J., Stubbe J. Solution structure of Co(III)-bleomycin-OOH bound to a phosphoglycolate lesion containing oligonucleotide: implications for bleomycin-induced double-strand DNA cleavage. Biochemistry. 40:2001;5894-5905.
32. Sucheck S.J., Ellena J.F., Hecht S.M. Characterization of Zn(II)-deglycobleomycin A(2) and interaction with d(CGCTAGCG)(2): direct evidence for minor groove binding of the bithiazole moiety. J Am Chem Soc. 120:1998;7450-7460.
33. Abraham A.T., Zhou X., Hecht S.M. Metallobleomycin-mediated cleavage of DNA not involving a threading-intercalation mechanism. J Am Chem Soc. 123:2001;5167-5175.
34. 2: evidence for binding by partial intercalation. Nucleic Acids Res. 30:2002;4881-4891 This article demonstrates that phleomycin (PLM) binds by partial intercalation, despite the fact that the penultimate thiazolium ring is partially reduced. Thus, the observation that PLM and BLM cleave DNA in vivo with similar efficiency does not negate the importance of the intercalative mode of binding of BLMs.
35. Choudhury A.K., Tao Z.F., Hecht S.M. Synthesis and DNA cleavage activity of a novel bleomycin A(5) glycoconjugate. Org Lett. 3:2001;1291-1294.
36. Absalon M.J., Wu W., Kozarich J.W., Stubbe J. Sequence-specific double-strand cleavage of DNA by Fe bleomycin. 2. Mechanism and dynamics. Biochemistry. 34:1995;2076-2086.
37. Hu Y., Walker S. Remarkable structural similarities between diverse glycosyltransferases. Chem Biol. 9:2002;1287-1296.
38. Losey H.C., Jiang J., Biggins J.B., Oberthur M., Ye X.Y., Dong S.D., Kahne D., Thorson J.S., Walsh C.T. Incorporation of glucose analogs by GtfE and GtfD from the vancomycin biosynthetic pathway to generate variant glycopeptides. Chem Biol. 9:2002;1305-1314.
39. Caceres-Cortes J., Sugiyama H., Ikudome K., Saito I., Wang A.H. Structures of cobalt(III)-pepleomycin and cobalt(III)-deglycopepleomycin (green forms) determined by NMR studies. Eur J Biochem. 244:1997;818-828.